USS Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-787,000
Closed -$115M 150
2017
Q3
$115M Sell
787,000
-140,000
-15% -$19.1M 0.89% 29
2017
Q2
$120M Hold
927,000
1.12% 21
2017
Q1
$115M Hold
927,000
1.59% 21
2016
Q4
$107M Hold
927,000
1.65% 23
2016
Q3
$96.9M Hold
927,000
1.49% 29
2016
Q2
$91.4M Hold
927,000
1.59% 23
2016
Q1
$92.8M Hold
927,000
1.56% 24
2015
Q4
$111M Sell
927,000
-210,000
-18% -$24.3M 1.83% 17
2015
Q3
$123M Hold
1,137,000
2.18% 12
2015
Q2
$132M Buy
1,137,000
+300,000
+36% +$34.3M 2.09% 10
2015
Q1
$96.5M Hold
837,000
1.58% 24
2014
Q4
$93.6M Hold
837,000
1.54% 27
2014
Q3
$79.3M Buy
+837,000
New +$75.5M 1.39% 31
2013
Q4
Sell
-104,524
Closed -$8.06M 87
2013
Q3
$8.06M Sell
104,524
-1,040,000
-91% -$72.9M 0.15% 81
2013
Q2
$66.9M Buy
+1,144,524
New +$68.9M 1.43% 27

Other funds holding CELG

USS Investment Management's CELG Position: Q4 2017 in Review

USS Investment Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 787,000 shares — an estimated $115M sold.

USS Investment Management first reported a position in CELG in Q2 2013 and held it in 15 quarters. The position peaked at $132M in Q2 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • USS Investment Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • USS Investment Management sold 787,000 Celgene Corp shares in Q4 2017, an estimated $115M.
  • USS Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 15 quarters.
  • USS Investment Management's Celgene Corp position peaked at $132M in Q2 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on USS Investment Management's 13F filing for Q4 2017, filed 16 Jan 2018.